Figure 6: Summary of the potential targets for the treatments of LUTD after SCI. Several targets for the better/new treatments of LUTD due to SCI were reviewed in this article. Some targets are responsible for the storage dysfunction and others are for the voiding dysfunction such as DSD. These targets or medications need to be translated to the clinical setting. Some of them including ivermectin, nintedanib, mucimol or baclofen (GABA agonists) might be repositioned to new indications. LUTD: Lower urinary tract dysfunction, SCI: Spinal cord injury, DSD: Detrusor-sphincter dyssynergia